艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

已收盘 09-02 16:00:00 EDT

261.72

+1.73

+0.67%

盘后261.60

-0.12-0.05%

19:59 EDT

最高262.97	最低257.70	成交量422.55万
今开262.70	昨收259.99	日振幅2.03%
总市值4,626亿	流通市值4,614亿	总股本17.67亿
成交额11.01亿	换手率0.24%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":261.72,"timestamp":1788379200000,"preClose":259.99,"halted":0,"volume":4225514,"hourTrading":{"tag":"盘后","latestPrice":261.6,"preClose":261.72,"latestTime":"19:59 EDT","volume":409231,"amount":107103539.8867,"timestamp":1788393582596,"change":-0.12,"changeRate":-0.000459,"amplitude":0.000497},"delay":0,"changeRate":0.006654102080849334,"floatShares":1762950764,"shares":1767384632,"eps":3.539701,"marketStatus":"已收盘","change":1.73,"latestTime":"09-02 16:00:00 EDT","open":262.7,"high":262.97,"low":257.7,"amount":1100627744.56688,"amplitude":0.02027,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.539701,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":259.99,"dividendRate":0.026097,"preHourTrading":{"tag":"盘前","latestPrice":261.69,"preClose":259.99,"latestTime":"09:25 EDT","volume":2564,"amount":669693.7239999999,"timestamp":1788355500027,"change":1.7,"changeRate":0.006539,"amplitude":0.01677},"postHourTrading":{"tag":"盘后","latestPrice":261.6,"preClose":261.72,"latestTime":"19:59 EDT","volume":409231,"amount":107103539.8867,"timestamp":1788393582596,"change":-0.12,"changeRate":-0.000459,"amplitude":0.000497},"volumeRatio":1.084535,"impliedVol":0.2675,"impliedVolPercentile":0.3214},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"1169611288","title":"FDA：不会启动撤销仿制药批准的流程——这些仿制药参照的是Namenda产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1169611288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169611288?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:55","pubTimestamp":1788180909,"startTime":"0","endTime":"0","summary":"根据《联邦公报》发布的信息，美国食品药品监督管理局（FDA）宣布，将不会启动撤销相关简化新药申请（ANDA）批准的程序。这些申请所参照的，正是涉及Namenda系列产品的上市申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LU0965509010.AUD","LU0122379950.USD","LU1093756168.USD","IE0004445239.USD","LU0965509101.SGD","LU1236620834.HKD","IE00BGHQF631.EUR","LU0114720955.EUR","LU0310800379.SGD","LU1718418525.SGD","LU0820561818.USD","LU1162221912.USD","RXL","LU1496350502.SGD","LU1003077747.HKD","LU0943347566.SGD","LU1670627923.USD","BK4566","LU1023059063.AUD","IE000F7OJYX1.SGD","LU0211327993.USD","LU0395794307.EUR","LU0158827948.USD","LU1244550221.USD","LU2089283258.USD","LU1989772923.USD","LU1061106388.HKD","JDOC","IE00B19Z3B42.SGD","LU0310799852.SGD","IE00BLSP4239.USD","ABBV","IE00BBT3K403.USD","SG9999015978.USD","FTXH","IE00BFTCPJ56.SGD","LU0203345920.USD","LU2133065610.SGD","LU0320765646.SGD","LU2357627491.SGD","LU2129689431.USD","LU0256863811.USD","LU2237443895.HKD","LU1670628061.USD","LU1291159041.SGD","LU2023251221.USD","LU0124676726.USD","LU0198837287.USD","LU2237443382.USD","LU1244550494.USD","LU1585245621.USD","LU2237443978.SGD","LU0820561909.HKD","LU2129689605.HKD","IE000SO60NU8.SGD","LU0738911758.USD","LU0795875169.SGD","LU2237443622.USD","SG9999003800.SGD","LU0289961442.SGD","LU1551013342.USD","LU1732799900.SGD","IE00BVYPNW00.USD","SG9999001440.SGD","LU1037948541.HKD","LU0057025933.USD","IXJ","LU0511384066.AUD","BK4559","LU1923622614.USD","IE0002270589.USD","BK4585","LU0069063385.USD","MEDX","IE00B42XCP33.USD","LU0708994859.HKD","LU1983299246.USD","LU0859254822.USD","VHT","LU0289739699.SGD","LU0203347892.USD","IE0002141913.USD","LU0234572021.USD","LU2112291526.USD","LU1496350171.SGD","LU0456855351.SGD","LU2347655073.USD","BK4550","LU1551013425.SGD","LU0289739343.SGD","LU0689626769.HKD","LU0170899867.USD","LU0553294199.USD","LU1244550577.SGD","LU0432979614.USD","XLV","IE000BZT7R73.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0949170772.SGD","SG9999015952.SGD","LU2237443465.HKD","FHLC","LU2087621335.USD","IE00BJJMRZ35.SGD","PPH","LU0234570918.USD","LU2125909593.SGD","LU0823416689.USD","LU0661504455.SGD","IE000MB6IJN5.SGD","LU0689472784.USD","LU1732800096.USD","GLAM","IE00B2B36J28.USD","LU1236620750.USD","LU0912757837.SGD","SG9999015945.SGD","BK4581","BK4534","LU2129689514.USD","LU0868494617.USD","IYH","BK4139","LU0098860793.USD","LU0417517546.SGD","BK4533","LU2125909247.SGD","LU2468319806.SGD","LU0795875086.SGD","LU0029864427.USD","IE0009355771.USD","LU1430594728.SGD","IE0000B7K699.USD","IE00BN8TJ469.HKD","LU1093756325.SGD","SG9999015986.USD","LU1934455194.USD","LU0128525929.USD","LU1934455277.USD","LU0256863902.USD","LU2347655156.SGD","LU0868494708.USD","LU0058720904.USD","LU0965509283.SGD","LU0726765562.USD","LU1934455863.HKD","LU2089284900.SGD","LU1057294990.SGD","LU1074936037.SGD","LU0882574055.USD","LU1989771016.USD","IE00B3PB1722.GBP","IE000WAW04H5.SGD","LU1989772840.SGD","LU2237443549.SGD","LU0985320562.USD","SG9999011175.SGD","LU0472753341.HKD","LU0942090050.USD","BK4588","LU0861579265.USD","PJP","LU1839511570.USD","LU1929549753.HKD","LU1267930490.SGD","IE00B19Z3581.USD","LU0965508806.USD","TRUH","LU0545039389.USD","LU0211328371.USD","LU1037948897.HKD","IE00BDGV0183.EUR","LU1267930573.SGD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639772","title":"伯维（ABBV）向EMA递交Skyrizi克罗恩病治疗上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639772","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662639772?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:56","pubTimestamp":1787821007,"startTime":"0","endTime":"0","summary":"Skyrizi此前已经在银屑病、银屑病关节炎等多个自身免疫疾病领域拿到欧洲地区的获批资质，如若本次克罗恩病适应症顺利获批，将进一步拓宽该产品在欧洲炎症性肠病赛道的市场空间。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","JDOC","FTXH","BK4559","ABBV","LU0058720904.USD","LU1989771016.USD","RXL","LU1839511570.USD","LU2087621335.USD","LU2125909593.SGD","EMA","LU0417517546.SGD","LU1585245621.USD","IE0004445239.USD","LU2133065610.SGD","GLAM","LU0234572021.USD","IPOS","LU1267930573.SGD","PJP","LU2023251221.USD","BK4533","LU0114720955.EUR","LU1236620750.USD","TRUH","LU2089283258.USD","LU1732799900.SGD","IXJ","LU0472753341.HKD","LU0198837287.USD","IYH","LU0882574055.USD","LU0985320562.USD","SG9999011175.SGD","VHT","LU2125909247.SGD","XLV","IE00BLSP4239.USD","LU0289739699.SGD","IE000F7OJYX1.SGD","LU0661504455.SGD","SG9999001440.SGD","LU2237443622.USD","PPH","LU1236620834.HKD","FHLC","LU0965508806.USD","MEDX","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195775229","title":"艾伯维向欧洲药品管理局提交Skyrizi®（瑞莎珠单抗）皮下诱导治疗申请，针对中重度活动性克罗恩病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1195775229","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195775229?lang=zh_cn&edition=full","pubTime":"2026-08-27 14:00","pubTimestamp":1787810433,"startTime":"0","endTime":"0","summary":"艾伯维公司已正式向欧洲药品管理局递交了一项监管申请，旨在寻求Skyrizi皮下注射剂型的上市许可。该申请针对的适应症为——用于治疗患有中重度活动性克罗恩病的成年患者，且此方案将作为诱导治疗手段。若此次申请获得批准，Skyrizi的皮下给药方式将为患者提供更为便捷的治疗选择，有望改善治疗依从性与患者体验。此次针对克罗恩病皮下诱导治疗的申请，进一步丰富了Skyrizi的潜在临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU0203347892.USD","LU0661504455.SGD","LU1551013342.USD","LU2347655073.USD","LU0795875086.SGD","IE00BLSP4452.SGD","LU1670627923.USD","LU1037948897.HKD","BK4139","LU0114720955.EUR","SG9999015986.USD","LU1023059063.AUD","LU1244550221.USD","LU0128525929.USD","LU2112291526.USD","LU1244550494.USD","LU0472753341.HKD","LU0965509283.SGD","LU1057294990.SGD","IE00BVYPNW00.USD","LU0310800379.SGD","LU1496350502.SGD","LU2023251221.USD","RXL","LU1934455194.USD","LU0234572021.USD","IE00BBT3K403.USD","LU1983299246.USD","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU0057025933.USD","LU1929549753.HKD","LU1037948541.HKD","LU2237443465.HKD","XLV","IE00BLSP4239.USD","LU0170899867.USD","LU0949170772.SGD","LU2433249047.HKD","LU0417517546.SGD","LU0553294199.USD","LU0820561818.USD","BK4588","SG9999001440.SGD","LU0310799852.SGD","LU1061106388.HKD","LU1093756325.SGD","SG9999015945.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","BK4559","IE00B42XCP33.USD","LU0395794307.EUR","LU0158827948.USD","LU0689626769.HKD","LU0943347566.SGD","IE00BVYPNV92.GBP","LU0098860793.USD","LU0820561909.HKD","IE00B3PB1722.GBP","LU1074936037.SGD","LU2129689431.USD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU0708994859.HKD","IE00B19Z3B42.SGD","LU1291159041.SGD","LU0124676726.USD","LU0256863902.USD","LU0985320562.USD","LU0122379950.USD","LU2089284900.SGD","MEDX","LU0069063385.USD","LU0234570918.USD","LU1496350171.SGD","LU0726765562.USD","LU0859254822.USD","LU0211327993.USD","LU0320765646.SGD","IE0004445239.USD","BK4533","SG9999011175.SGD","JDOC","IE000SO60NU8.SGD","LU0211328371.USD","IE0002141913.USD","BK4550","BK4585","IE000WAW04H5.SGD","PPH","LU2237443382.USD","LU0198837287.USD","LU2357627491.SGD","LU2129689514.USD","LU1934455277.USD","LU1585245621.USD","IE000MB6IJN5.SGD","IE00BFTCPJ56.SGD","LU2089283258.USD","LU0029864427.USD","LU0456855351.SGD","LU0882574055.USD","IE0002270589.USD","LU1732799900.SGD","LU2125909247.SGD","SG9999015952.SGD","IE0009355771.USD","LU0868494708.USD","LU1236620750.USD","BK4581","LU2237443549.SGD","FTXH","IE0000B7K699.USD","LU0942090050.USD","LU0965509010.AUD","LU2133065610.SGD","LU1551013425.SGD","LU1732800096.USD","VHT","LU0868494617.USD","FHLC","LU0511384066.AUD","IE00B2B36J28.USD","LU1989772840.SGD","LU0965508806.USD","LU2468319806.SGD","IXJ","LU0256863811.USD","LU1267930573.SGD","LU0545039389.USD","LU1923622614.USD","BK4534","LU2129689605.HKD","LU0823416689.USD","BK4566","LU0912757837.SGD","LU0795875169.SGD","LU2125909593.SGD","ABBV","IE00BSNM7G36.USD","LU0689472784.USD","LU1670628061.USD","GLAM","LU1003077747.HKD","PJP","AGNG","LU0289961442.SGD","LU0965509101.SGD","LU1989772923.USD","LU1267930490.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","LU2237443895.HKD","LU1093756168.USD","LU1236620834.HKD","LU0289739699.SGD","LU1718418525.SGD","LU1839511570.USD","LU2237443622.USD","LU0289739343.SGD","LU0432979614.USD","IE00BN8TJ469.HKD","LU1934455863.HKD","TRUH","IE00B19Z3581.USD","LU0861579265.USD","LU2347655156.SGD","LU0738911758.USD","LU2237443978.SGD","SG9999003800.SGD","IE000F7OJYX1.SGD","SG9999015978.USD","LU1162221912.USD","LU1430594728.SGD","LU0058720904.USD","LU0203345920.USD","LU1244550577.SGD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193640360","title":"异动解读｜艾伯维公司盘中上涨3.04%，多家投行密集上调目标价叠加管线催化延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1193640360","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193640360?lang=zh_cn&edition=full","pubTime":"2026-08-20 03:36","pubTimestamp":1787168214,"startTime":"0","endTime":"0","summary":"8月19日，艾伯维公司盘中上涨3.04%，报266.765美元/股，成交额8.13亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价：Wolfe将评级上调至\"跑赢大盘\"并给予300美元目标价，富国银行上调目标价至300美元维持增持，巴克莱上调至300美元，摩根大通上调至285美元，美银上调至276美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156251729","title":"异动解读｜艾伯维公司盘中上涨3.03%，多家投行上调目标价叠加管线催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1156251729","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156251729?lang=zh_cn&edition=full","pubTime":"2026-08-19 00:19","pubTimestamp":1787069954,"startTime":"0","endTime":"0","summary":"8月19日，艾伯维公司盘中上涨3.03%，报257.915美元/股，成交额4.05亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价。管线方面，艾伯维近日在ClinicalTrials平台登记了从荣昌生物引进的PD-1/VEGF双抗RC148全球III期临床试验，头对头对照帕博利珠单抗联合化疗用于一线非小细胞肺癌，标志着该资产进入后期开发阶段，进一步丰富公司肿瘤管线布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656597285","title":"艾伯维（ABBV）保妥适新适应症获FDA受理 有望成美国首款咬肌突出医美肉毒制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2656597285","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656597285?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:03","pubTimestamp":1785848630,"startTime":"0","endTime":"0","summary":"艾伯维表示，本次申报是对成熟产品潜力的进一步挖掘，以此匹配不断变化的求美者需求。作为医美赛道重磅单品，新适应症如若获批，有望进一步巩固艾尔建美学在注射医美领域的市场地位。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","FTXH","LU0820561818.USD","SG9999015952.SGD","LU1989772923.USD","GLAM","LU0942090050.USD","LU1989771016.USD","LU0738911758.USD","IE000MB6IJN5.SGD","BK4588","LU2089283258.USD","LU0965509010.AUD","AGNG","SG9999015945.SGD","LU1670627923.USD","JDOC","IE000BZT7R73.USD","LU0158827948.USD","LU0098860793.USD","PPH","LU0289739699.SGD","TRUH","LU0708994859.HKD","LU2433249047.HKD","IXJ","LU0553294199.USD","IE00B3PB1722.GBP","LU1430594728.SGD","LU0912757837.SGD","LU2129689605.HKD","RXL","XLV","IE000SO60NU8.SGD","LU2125909593.SGD","FHLC","LU1670628061.USD","VHT","LU0320765646.SGD","LU0795875169.SGD","MEDX","LU2129689431.USD","LU0868494708.USD","ABBV","IE00B2B36J28.USD","LABU","LU1496350502.SGD","PJP","LU0965509101.SGD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175108203","title":"艾伯维三期临床研究达标：主要终点相较安慰剂实现统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1175108203","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175108203?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:04","pubTimestamp":1785845057,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）宣布，其三期临床研究成功达成主要终点，与安慰剂相比，展现出统计学意义上的显著改善。这一结果标志着该药物研发进程中的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU0058720904.USD","LU0256863902.USD","LU0029864427.USD","LU1551013342.USD","LU2125909593.SGD","LU2357627491.SGD","LU1430594728.SGD","LU2237443382.USD","LU1496350171.SGD","LU0234572021.USD","IE00B19Z3581.USD","LU1551013425.SGD","LU1929549753.HKD","IE00B3PB1722.GBP","LU1732799900.SGD","LU0310799852.SGD","BK4566","LU0198837287.USD","LU0320765646.SGD","LU0882574055.USD","LU0124676726.USD","LU1093756325.SGD","LU1670628061.USD","LU0211328371.USD","LU1934455277.USD","LU0965509010.AUD","XLV","LU0289739699.SGD","LU0395794307.EUR","LU0912757837.SGD","LU2347655073.USD","LU1718418525.SGD","LU2433249047.HKD","LU2237443622.USD","BK4139","LU1923622614.USD","IE000MB6IJN5.SGD","IE00BGHQF631.EUR","LU1093756168.USD","LU0128525929.USD","PPH","IE0002270589.USD","FTXH","BK4559","LU2468319806.SGD","ABBV","IE00BJT1NW94.SGD","LU2237443978.SGD","LU1074936037.SGD","RXL","LU1037948897.HKD","LU0417517546.SGD","LU0456855351.SGD","LU1244550577.SGD","LU2133065610.SGD","GLAM","IE00BJJMRZ35.SGD","LU1244550221.USD","LU2129689514.USD","LU2023251221.USD","IE00BFTCPJ56.SGD","LU0069063385.USD","LU0795875169.SGD","LU0868494617.USD","LU0472753341.HKD","BK4588","IXJ","IYH","IE00B19Z3B42.SGD","LU2237443549.SGD","SG9999011175.SGD","LU0689472784.USD","IE000WAW04H5.SGD","LU0289739343.SGD","LU1244550494.USD","IE000F7OJYX1.SGD","LU2129689431.USD","LU0661504455.SGD","LU1496350502.SGD","LU1983299246.USD","LU0738911758.USD","LU0965509283.SGD","FHLC","LU0203345920.USD","LU2347655156.SGD","MEDX","LU2087621335.USD","LU0211327993.USD","AGNG","JDOC","LU0795875086.SGD","IE00B2B36J28.USD","LU1989771016.USD","LU0098860793.USD","LU0158827948.USD","IE00BDGV0183.EUR","LU0943347566.SGD","LU1003077747.HKD","LU1839511570.USD","LU0234570918.USD","LU0289961442.SGD","IE00BVYPNV92.GBP","IE000BZT7R73.USD","LU1585245621.USD","IE00BLSP4452.SGD","IE0004445239.USD","SG9999015978.USD","BK4585","IE0000B7K699.USD","LU1267930573.SGD","LU1934455194.USD","IE00BSNM7G36.USD","LU0553294199.USD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BBT3K403.USD","LU0820561818.USD","LU0868494708.USD","LU2112291526.USD","TRUH","LU0170899867.USD","LU1989772840.SGD","LU2089283258.USD","VHT","IE0002141913.USD","LU0985320562.USD","LU0708994859.HKD","LU0942090050.USD","LU2089284900.SGD","LU0689626769.HKD","LU0057025933.USD","LU0310800379.SGD","LU0203347892.USD","LU1267930490.SGD","SG9999001440.SGD","LU0823416689.USD","LU0256863811.USD","LU1934455863.HKD","LU0949170772.SGD","LU2089984988.USD","SG9999015986.USD","LU0820561909.HKD","BK4581","IE00BVYPNW00.USD","SG9999003800.SGD","LU0726765562.USD","LU1291159041.SGD","LU2237443465.HKD","IE00BN8TJ469.HKD","BK4550","LU1037948541.HKD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0114720955.EUR","LU1989772923.USD","IE000SO60NU8.SGD","LU0545039389.USD","LU1162221912.USD","LU2237443895.HKD","LU0965509101.SGD","LU0511384066.AUD","LU0861579265.USD","LU2129689605.HKD","LU0859254822.USD","LU2125909247.SGD","SG9999015945.SGD","LU1023059063.AUD","IE00BLSP4239.USD","LU1061106388.HKD","LU1732800096.USD","BK4534","SG9999015952.SGD","LU0965508806.USD","LU1670627923.USD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173570619","title":"艾伯维旗下艾尔建美学宣布：保妥适®美容（用于咬肌突出）补充生物制剂许可申请获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1173570619","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173570619?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:02","pubTimestamp":1785844948,"startTime":"0","endTime":"0","summary":"艾伯维（AbbVie）旗下艾尔建美学（Allergan Aesthetics）今日正式对外宣告，其针对保妥适®美容（Botox® Cosmetic）用于改善咬肌突出问题的补充生物制剂许可申请（sBLA），已成功获得美国食品药品监督管理局（FDA）的受理。这一进展标志着该产品在拓展适应症领域迈出了关键一步，有望为相关需求人群提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU1267930573.SGD","LU0965509283.SGD","LU0289961442.SGD","SG9999015952.SGD","LU0098860793.USD","LU1989771016.USD","BK4566","LU0198837287.USD","LU1934455194.USD","IE000MB6IJN5.SGD","IE00BVYPNV92.GBP","LU0069063385.USD","LU2125909593.SGD","LU0795875169.SGD","RXL","IE00B19Z3581.USD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","IE00BVYPNW00.USD","LU1551013425.SGD","SG9999001440.SGD","LU0203347892.USD","LU0545039389.USD","LU2023251221.USD","LU1989772923.USD","PPH","LU2089283258.USD","IE0000B7K699.USD","LU0689626769.HKD","SG9999011175.SGD","LU0234570918.USD","LU1430594728.SGD","LU2433249047.HKD","LU1934455277.USD","LU2129689431.USD","LU1093756168.USD","IE0002270589.USD","LU0942090050.USD","IE00BBT3K403.USD","LU2237443622.USD","LU1585245621.USD","JDOC","LU0868494617.USD","IE000BZT7R73.USD","LU0861579265.USD","IE00BLSP4452.SGD","LU0859254822.USD","LU0882574055.USD","LU2089984988.USD","LU1983299246.USD","FHLC","LU1037948897.HKD","LU1934455863.HKD","LU0114720955.EUR","LU0256863811.USD","LU2237443978.SGD","LU2237443382.USD","LU2129689514.USD","IE00BJJMRZ35.SGD","ABBV","BK4559","IE00B42XCP33.USD","BK4581","LU0726765562.USD","IE00BN8TJ469.HKD","LU0170899867.USD","LU0708994859.HKD","LU0122379950.USD","LU1989772840.SGD","IE0009355771.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU1003077747.HKD","LU1244550577.SGD","LU1496350502.SGD","GLAM","LU0965509101.SGD","LU1093756325.SGD","LU2112291526.USD","LU0289739343.SGD","LU0868494708.USD","IE0004445239.USD","LU1732799900.SGD","IE000F7OJYX1.SGD","LU0310799852.SGD","LU1923622614.USD","SG9999015978.USD","SG9999015945.SGD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU0689472784.USD","LU0738911758.USD","LU0310800379.SGD","LU0472753341.HKD","LU0289739699.SGD","LU2237443895.HKD","TRUH","LU0058720904.USD","LU0320765646.SGD","LU2129689605.HKD","IE0002141913.USD","XLV","LU0395794307.EUR","LU1670628061.USD","IE00BFTCPJ56.SGD","BK4139","LU0511384066.AUD","LU0417517546.SGD","LU1162221912.USD","LU0029864427.USD","LU2237443465.HKD","LU0158827948.USD","MEDX","IE00B3PB1722.GBP","AGNG","LU0456855351.SGD","LU1037948541.HKD","FTXH","LU1496350171.SGD","LU1670627923.USD","VHT","LU0256863902.USD","SG9999003800.SGD","IE00BLSP4239.USD","LU1244550494.USD","LU1839511570.USD","LU1551013342.USD","LU0234572021.USD","LU0820561818.USD","LU2237443549.SGD","LU0823416689.USD","SG9999015986.USD","LU0795875086.SGD","IE00B4R5TH58.HKD","LU0985320562.USD","LU0124676726.USD","LU2089284900.SGD","IE00BDGV0183.EUR","IYH","LU0211327993.USD","LU1061106388.HKD","LU1244550221.USD","LU0128525929.USD","BK4585","LU0553294199.USD","LU2087621335.USD","IE00B19Z3B42.SGD","LU1291159041.SGD","LU0949170772.SGD","LU1023059063.AUD","BK4588","IE00B2B36J28.USD","LU0661504455.SGD","LU0820561909.HKD","IXJ","LU2125909247.SGD","LU0912757837.SGD","BK4550","LU0432979614.USD","LU0943347566.SGD","LU2347655156.SGD","BK4533","LU1929549753.HKD","IE00BGHQF631.EUR","LU1718418525.SGD","LU2468319806.SGD","LU2347655073.USD","LU1267930490.SGD","LU1057294990.SGD","LU1074936037.SGD","LU0211328371.USD","LU2357627491.SGD","LU1732800096.USD","BK4534","LU0057025933.USD","LU0965508806.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107633372","title":"异动解读｜艾伯维公司盘中下跌3.04%，Q2业绩超预期但全年盈利指引因收购摊薄下调","url":"https://stock-news.laohu8.com/highlight/detail?id=1107633372","media":"行情直击","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107633372?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:04","pubTimestamp":1785506697,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘中下跌3.04%，报251.87美元/股，成交额3.18亿美元。然而，公司将全年调整后每股收益指引下调至13.87至14.07美元，低于此前的13.91至14.11美元，亦低于市场预期的14.06美元。指引下调主要源于收购Apogee Therapeutics带来的每股约0.14美元摊薄影响，以及第二季度计入的2.91亿美元IPR&D费用对每股收益造成的0.17美元拖累。业绩兑现后，市场对全年盈利前景的担忧触发获利回吐。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154857507","title":"艾伯维Q2业绩超预期，Skyrizi与Rinvoq表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1154857507","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154857507?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:37","pubTimestamp":1785505047,"startTime":"0","endTime":"0","summary":"摩根大通分析师在最新研究报告中指出，艾伯维公司第二季度财报业绩超出市场预期。营收超预期表现颇为广泛——其中，Skyrizi和Rinvoq这两款药物的销售数据均小幅超过预估。分析师补充道：\"在接下来的业绩电话会上，我们将密切关注两大核心议题：其一，Skyrizi和Rinvoq的市场渗透率是否出现变化，以及针对这两款药物的最新业绩指引；其二，关于业务拓展方面的战略表态。\"值得注意的是，艾伯维在早盘交易中下跌1%。此前，该公司下调了全年调整后盈利预期，主要归因于其对Apogee Therapeutics的收购交易。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU2237443549.SGD","LU0472753341.HKD","IE00BSNM7G36.USD","JDOC","LU1496350502.SGD","LU0289739699.SGD","LU0098860793.USD","MEDX","LU1551013425.SGD","LU1934455277.USD","IE00BFTCPJ56.SGD","LU1989772840.SGD","SG9999015952.SGD","LU2089283258.USD","LU0912757837.SGD","LU2089984988.USD","LU1267930490.SGD","LU0985320562.USD","IE00B4R5TH58.HKD","LU0661504455.SGD","LU0823416689.USD","LU0738911758.USD","LU2347655156.SGD","BK4581","RXL","LU0553294199.USD","LU0320765646.SGD","IE000MB6IJN5.SGD","LU0234570918.USD","IE000WAW04H5.SGD","LU1732799900.SGD","LU1839511570.USD","IYH","LU0726765562.USD","LU0868494708.USD","SG9999011175.SGD","LU0395794307.EUR","LU1162221912.USD","LU1551013342.USD","LU1670627923.USD","LU1430594728.SGD","LU2112291526.USD","IE0000B7K699.USD","LU0203347892.USD","AGNG","IE00BBT3K403.USD","LU1244550494.USD","LU2237443895.HKD","LU1057294990.SGD","LU1037948897.HKD","LU2125909247.SGD","LU0417517546.SGD","BK4139","LU0949170772.SGD","LU0708994859.HKD","LU0124676726.USD","IE00B2B36J28.USD","IE00B3PB1722.GBP","LU0234572021.USD","LU0943347566.SGD","LU0114720955.EUR","LU1023059063.AUD","LU0456855351.SGD","LU0211327993.USD","LU2125909593.SGD","LU0965509010.AUD","IE00B19Z3B42.SGD","LU1585245621.USD","LU1291159041.SGD","BK4534","IE00BDGV0183.EUR","LU0545039389.USD","LU2023251221.USD","IE0002141913.USD","PPH","LU2357627491.SGD","LU0795875086.SGD","LU0029864427.USD","LU1496350171.SGD","LU1670628061.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU2129689514.USD","LU1934455194.USD","LU0211328371.USD","LU0289961442.SGD","LU1093756325.SGD","LU2237443622.USD","LU1732800096.USD","IXJ","LU0882574055.USD","LU0158827948.USD","SG9999003800.SGD","LU0820561909.HKD","IE000F7OJYX1.SGD","LU2468319806.SGD","VHT","LU1989771016.USD","LU0859254822.USD","PJP","LU2347655073.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU0942090050.USD","LU1929549753.HKD","IE00B42XCP33.USD","LU2087621335.USD","BK4585","IE000SO60NU8.SGD","LU0820561818.USD","LU1003077747.HKD","IE00B19Z3581.USD","LU0310799852.SGD","LU0861579265.USD","IE0004445239.USD","LU1244550221.USD","BK4559","LU1923622614.USD","LU0965509283.SGD","LU2237443978.SGD","LU0965508806.USD","LU0170899867.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU0203345920.USD","FHLC","GLAM","BK4566","LU0057025933.USD","TRUH","LU0122379950.USD","LU1934455863.HKD","LU0689626769.HKD","LU0965509101.SGD","IE00BGHQF631.EUR","LU1037948541.HKD","LU2089284900.SGD","BK4588","LU0689472784.USD","IE00BLSP4239.USD","LU2129689605.HKD","BK4533","LU1989772923.USD","LU2133065610.SGD","LU2237443465.HKD","LU0511384066.AUD","SG9999015978.USD","LU0069063385.USD","LU0256863902.USD","LU1074936037.SGD","IE0002270589.USD","LU1244550577.SGD","LU0432979614.USD","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU0058720904.USD","LU0310800379.SGD","LU1061106388.HKD","LU2433249047.HKD","LU0128525929.USD","IE000BZT7R73.USD","XLV","IE00BVYPNV92.GBP","FTXH","LU1718418525.SGD","SG9999001440.SGD","LU0795875169.SGD","LU1983299246.USD","SG9999015945.SGD","LU0198837287.USD","SG9999015986.USD","LU1093756168.USD","LU2237443382.USD","LU0289739343.SGD","LU2129689431.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127614771","title":"艾伯维高管透露：第三季度调整后每股收益预计在3.84至3.88美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1127614771","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127614771?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:34","pubTimestamp":1785504866,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，预计第三季度调整后每股收益将在3.84至3.88美元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4559","LU0738911758.USD","LU0289739343.SGD","LU2129689514.USD","LU0203347892.USD","LU0310799852.SGD","LU0158827948.USD","LU0965509283.SGD","LU1551013342.USD","LU1923622614.USD","LU0823416689.USD","SG9999015986.USD","LU0820561909.HKD","LU1244550494.USD","SG9999015952.SGD","IE00BFTCPJ56.SGD","LU1244550221.USD","LU1037948897.HKD","FHLC","LU0432979614.USD","LU0057025933.USD","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU0689472784.USD","IE00BLSP4239.USD","LU2237443549.SGD","LU0965509101.SGD","SG9999015945.SGD","LU2237443978.SGD","IE00B3PB1722.GBP","RXL","LU0511384066.AUD","LU1934455277.USD","LU2237443382.USD","BK4533","BK4581","LU2129689431.USD","LU1551013425.SGD","IE000MB6IJN5.SGD","LU0820561818.USD","LU0124676726.USD","LU0942090050.USD","IE000SO60NU8.SGD","IYH","LU2129689605.HKD","IE00BN8TJ469.HKD","LU2347655156.SGD","LU1718418525.SGD","LU2433249047.HKD","LU0128525929.USD","LU0395794307.EUR","IE000WAW04H5.SGD","IE00BDGV0183.EUR","LU2357627491.SGD","LU0912757837.SGD","LU0256863902.USD","LU1093756168.USD","LU0868494708.USD","LU2089283258.USD","LU0234570918.USD","LU1037948541.HKD","LU0289739699.SGD","VHT","LU0203345920.USD","LU0256863811.USD","LU0545039389.USD","IE0009355771.USD","IE00B42XCP33.USD","AGNG","LU1989772840.SGD","LU1934455194.USD","LU0029864427.USD","LU1061106388.HKD","IE00BLSP4452.SGD","LU1267930573.SGD","LU2468319806.SGD","LU1989771016.USD","LU2112291526.USD","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","LU2237443622.USD","IE0004445239.USD","IE0002141913.USD","LU1057294990.SGD","LU0795875086.SGD","SG9999015978.USD","LU0965508806.USD","LU0689626769.HKD","LU2347655073.USD","LU1430594728.SGD","LU0795875169.SGD","LU1732800096.USD","IE00BGHQF631.EUR","LU0882574055.USD","GLAM","IXJ","LU0198837287.USD","LU2133065610.SGD","SG9999011175.SGD","SG9999003800.SGD","LU1162221912.USD","LU1074936037.SGD","IE0000B7K699.USD","LU1244550577.SGD","BK4588","IE00BJT1NW94.SGD","MEDX","LU0122379950.USD","LU1267930490.SGD","LU2125909247.SGD","LU1983299246.USD","IE00B19Z3B42.SGD","LU0069063385.USD","LU1934455863.HKD","LU1929549753.HKD","BK4139","LU1839511570.USD","PJP","LU1496350502.SGD","LU2237443465.HKD","LU0170899867.USD","LU1496350171.SGD","LU2125909593.SGD","IE00B2B36J28.USD","LU1670628061.USD","LU0726765562.USD","LU1023059063.AUD","PPH","LU2023251221.USD","LU1003077747.HKD","LU0417517546.SGD","XLV","TRUH","LU2089284900.SGD","IE0002270589.USD","IE00BVYPNV92.GBP","LU0234572021.USD","LU0661504455.SGD","LU1585245621.USD","LU1989772923.USD","FTXH","SG9999001440.SGD","LU0861579265.USD","LU0965509010.AUD","LU0868494617.USD","IE00B19Z3581.USD","LU0472753341.HKD","IE00BBT3K403.USD","IE000BZT7R73.USD","LU0553294199.USD","BK4585","IE00BVYPNW00.USD","LU2237443895.HKD","LU1291159041.SGD","LU0859254822.USD","LU0289961442.SGD","LU0211327993.USD","LU0456855351.SGD","LU2089984988.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU0058720904.USD","BK4566","LU1732799900.SGD","LU1093756325.SGD","LU1670627923.USD","LU0310800379.SGD","JDOC","LU0320765646.SGD","LU0949170772.SGD","LU0211328371.USD","LU0708994859.HKD","LU0098860793.USD","ABBV","LU0114720955.EUR","BK4550","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161700508","title":"艾伯维高管透露：全年净营收预期上调至约676亿美元，较此前预测增加3亿美元——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1161700508","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161700508?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:28","pubTimestamp":1785504492,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，目前预计全年总净营收将达到约676亿美元。这一数字相较于此前预测，上调了整整3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU0738911758.USD","LU2089284900.SGD","LU0456855351.SGD","ABBV","LU0198837287.USD","LU0553294199.USD","LU2112291526.USD","LU0661504455.SGD","LU0882574055.USD","SG9999001440.SGD","IE000MB6IJN5.SGD","LU0234572021.USD","LU1267930490.SGD","LU0320765646.SGD","LU1934455194.USD","LU0057025933.USD","LU0203347892.USD","LU2237443622.USD","IE000F7OJYX1.SGD","JDOC","LU2347655073.USD","LU0289739343.SGD","IYH","IE000BZT7R73.USD","LU1003077747.HKD","LU1496350171.SGD","SG9999003800.SGD","SG9999015945.SGD","LU0289961442.SGD","IE00BFTCPJ56.SGD","LU0029864427.USD","LU2468319806.SGD","IE00BN8TJ469.HKD","LU1551013342.USD","SG9999015978.USD","LU0122379950.USD","LU0511384066.AUD","AGNG","BK4581","LU1718418525.SGD","LU1244550494.USD","LU2129689431.USD","LU0395794307.EUR","IE00BBT3K403.USD","LU1496350502.SGD","LU2357627491.SGD","BK4585","LU1093756325.SGD","LU1057294990.SGD","XLV","LU2129689514.USD","LU1934455863.HKD","LU2125909247.SGD","IE00B3PB1722.GBP","LU1430594728.SGD","LU1929549753.HKD","LU1037948897.HKD","LU0417517546.SGD","IE00B19Z3581.USD","RXL","LU0256863902.USD","LU1670628061.USD","LU1585245621.USD","LU0859254822.USD","LU0234570918.USD","IE00BSNM7G36.USD","LU0912757837.SGD","LU0726765562.USD","LU0114720955.EUR","IE000SO60NU8.SGD","GLAM","IE00BLSP4452.SGD","LU0942090050.USD","LU0795875086.SGD","LU0211328371.USD","IE00BJT1NW94.SGD","LU0211327993.USD","LU0868494708.USD","LU2237443978.SGD","LU2347655156.SGD","TRUH","LU1023059063.AUD","IE00BLSP4239.USD","LU1267930573.SGD","LU1989772840.SGD","LU0098860793.USD","IE00B2B36J28.USD","BK4139","LU2023251221.USD","IE0002141913.USD","LU0432979614.USD","LU0820561909.HKD","LU0965509283.SGD","LU2087621335.USD","LU0128525929.USD","LU0943347566.SGD","LU1551013425.SGD","IE0002270589.USD","IE0009355771.USD","LU1037948541.HKD","LU0158827948.USD","LU0545039389.USD","BK4533","LU2433249047.HKD","LU2125909593.SGD","LU2129689605.HKD","LU2237443382.USD","LU1983299246.USD","LU1074936037.SGD","LU1291159041.SGD","IXJ","LU0472753341.HKD","BK4588","LU2237443895.HKD","LU0069063385.USD","LU0823416689.USD","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU1162221912.USD","LU1093756168.USD","LU1934455277.USD","LU1732799900.SGD","LU0949170772.SGD","LU0170899867.USD","LU0124676726.USD","LU1732800096.USD","LU2089984988.USD","LU2133065610.SGD","BK4534","FTXH","LU1839511570.USD","LU1923622614.USD","LU0708994859.HKD","IE0000B7K699.USD","SG9999015952.SGD","IE000WAW04H5.SGD","LU0058720904.USD","IE00BVYPNV92.GBP","PPH","LU1989772923.USD","LU0861579265.USD","LU0965508806.USD","BK4559","LU0310800379.SGD","IE0004445239.USD","LU2237443465.HKD","IE00BVYPNW00.USD","LU0289739699.SGD","LU0256863811.USD","SG9999015986.USD","VHT","LU0689626769.HKD","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4550","LU1670627923.USD","IE00BDGV0183.EUR","LU0965509010.AUD","IE00BJJMRZ35.SGD","IE00BGHQF631.EUR","MEDX","LU0795875169.SGD","LU0965509101.SGD","LU0310799852.SGD","LU2089283258.USD","LU1989771016.USD","LU1244550221.USD","FHLC","LU0820561818.USD","PJP","LU0689472784.USD","LU0985320562.USD","LU1244550577.SGD","IE00B42XCP33.USD","LU2237443549.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177080903","title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1177080903","media":"老虎资讯综合","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177080903?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:18","pubTimestamp":1785500326,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前跌近4%，报247.52美元。消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120758809","title":"异动解读｜艾伯维公司盘前下跌4.29%，Q2业绩超预期但收购摊薄压制全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1120758809","media":"行情直击","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120758809?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:53","pubTimestamp":1785498788,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前下跌4.29%，报250.0美元/股，成交额202.1万美元。消息面上，公司发布第二季度财报，调整后每股收益3.65美元，超市场预期的3.60美元；营收169.90亿美元，超预期的167.65亿美元，同比增幅显著。此前公司股价在多重利好推动下已累计大幅上涨，巴克莱等多家机构上调目标价，市场对财报预期充分定价，业绩兑现后获利回吐压力明显。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158299319","title":"艾伯维：2026财年调整后每股收益指引包含收购Apogee Therapeutics带来的每股0.14美元摊薄影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1158299319","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158299319?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498494,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）近日披露，其2026财年调整后的每股收益（EPS）指引中，已纳入了因收购Apogee Therapeutics而产生的每股约0.14美元的摊薄效应。这一财务影响，直接在预期利润数据中体现，显示出公司对近期并购交易成本进行的前瞻性评估。通过此次收购，艾伯维正积极推进其战略布局，但短期内，该交易将对每股收益构成一定压力。市场分析师正密切关注这一指引，以评估其对公司未来盈利能力的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","GLAM","LU0738911758.USD","IE000MB6IJN5.SGD","LU0965509010.AUD","LU1929549753.HKD","IE00BVYPNV92.GBP","LU0069063385.USD","IE0002270589.USD","JDOC","LU0289739343.SGD","LU0170899867.USD","PPH","LU0289739699.SGD","LU1023059063.AUD","LU2129689514.USD","LU0708994859.HKD","LU1732799900.SGD","LU1093756168.USD","LU2347655156.SGD","LU0912757837.SGD","IE0004445239.USD","RXL","XLV","BK4581","LU0511384066.AUD","LU1551013425.SGD","LU0234570918.USD","LU1670628061.USD","LU0320765646.SGD","IE00BJT1NW94.SGD","LU2129689431.USD","LU0868494708.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1496350502.SGD","IE00BSNM7G36.USD","LU2357627491.SGD","PJP","LU0211327993.USD","LU1496350171.SGD","LU2237443382.USD","LU0456855351.SGD","LU2237443549.SGD","SG9999011175.SGD","LU1244550577.SGD","LU0985320562.USD","LU1585245621.USD","LU1989772923.USD","SG9999015952.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","IE000WAW04H5.SGD","LU1670627923.USD","IE00BLSP4452.SGD","IE000F7OJYX1.SGD","LU0823416689.USD","LU2087621335.USD","LU0124676726.USD","LU0158827948.USD","LU1057294990.SGD","BK4534","LU2133065610.SGD","LU2237443622.USD","LU2023251221.USD","LU2433249047.HKD","IE00B42XCP33.USD","IE00B3PB1722.GBP","LU0198837287.USD","LU2237443465.HKD","LU1430594728.SGD","LU2237443978.SGD","LU2129689605.HKD","LU2125909593.SGD","FHLC","LU0256863902.USD","VHT","SG9999003800.SGD","LU1093756325.SGD","LU1244550494.USD","BK4533","LU0310799852.SGD","BK4585","LU1291159041.SGD","IE00BN8TJ469.HKD","LU0689472784.USD","FTXH","LU0820561818.USD","LU0472753341.HKD","LU1074936037.SGD","IE00BGHQF631.EUR","LU0859254822.USD","BK4588","BK4559","LU1923622614.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU0029864427.USD","LU0057025933.USD","BK4566","SG9999001440.SGD","LU0820561909.HKD","SG9999015978.USD","LU0545039389.USD","LU0203345920.USD","BK4139","LU0256863811.USD","LU0661504455.SGD","IXJ","LU0553294199.USD","LU0795875086.SGD","LU1983299246.USD","IE000SO60NU8.SGD","IE0009355771.USD","LU0203347892.USD","LU0795875169.SGD","LU0310800379.SGD","LU0965509283.SGD","IE00BDGV0183.EUR","LU0417517546.SGD","LU1244550221.USD","LU1003077747.HKD","LU0289961442.SGD","IE00BBT3K403.USD","LU0943347566.SGD","LU1718418525.SGD","IYH","LU1267930573.SGD","BK4550","LU0432979614.USD","LU1732800096.USD","LU1037948541.HKD","LU1934455277.USD","LU0234572021.USD","LU0868494617.USD","LU0861579265.USD","LU1934455863.HKD","LU2089984988.USD","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU0882574055.USD","LU1989771016.USD","LU2125909247.SGD","LU2089283258.USD","LU2112291526.USD","SG9999015945.SGD","AGNG","IE0002141913.USD","LU0689626769.HKD","LU0211328371.USD","LU1551013342.USD","IE000BZT7R73.USD","LU0098860793.USD","LU0949170772.SGD","SG9999015986.USD","TRUH","LU1839511570.USD","LU1267930490.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU1162221912.USD","IE0000B7K699.USD","LU0058720904.USD","LU2347655073.USD","LU1934455194.USD","LU1037948897.HKD","LU2237443895.HKD","MEDX","IE00BVYPNW00.USD","ABBV","LU0965508806.USD","LU0395794307.EUR","LU1989772840.SGD","IE00B19Z3B42.SGD","LU0965509101.SGD","LU2089284900.SGD","LU0726765562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191974640","title":"艾伯维公司：第二季度业绩受收购IPR&D及里程碑费用影响，每股收益减少0.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191974640","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191974640?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498491,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）公布的第二季度财报显示，因收购过程中的在研项目（IPR&D）及里程碑费用支出，其每股收益遭遇了0.17美元的不利冲击。这一财务指标的下滑，主要源于相关并购活动产生的成本摊销。具体来看，这些费用直接拖累了公司本季度的盈利表现，使得每股收益数据承压。尽管面临此类短期财务挑战，但公司整体运营仍保持稳健。市场分析人士指出，此类一次性支出虽会影响短期业绩，但却是公司长期战略布局中不可或缺的一部分，旨在通过外部研发合作和里程碑式进展来巩固未来增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0029864427.USD","TRUH","LU0211328371.USD","LU0432979614.USD","IE00B3PB1722.GBP","BK4581","LU1430594728.SGD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU0456855351.SGD","LU2433249047.HKD","IE00B19Z3B42.SGD","LU2129689431.USD","LU2237443978.SGD","IXJ","LU1093756325.SGD","LU2125909247.SGD","LU1585245621.USD","LU0234570918.USD","LU0511384066.AUD","IE000F7OJYX1.SGD","LU0069063385.USD","LU2237443622.USD","LU0114720955.EUR","LU1718418525.SGD","IE000BZT7R73.USD","LU0738911758.USD","LU0234572021.USD","LU1934455277.USD","LU1496350171.SGD","LU0098860793.USD","LU2347655073.USD","LU1057294990.SGD","LU1291159041.SGD","LU1670628061.USD","IE000WAW04H5.SGD","LU0211327993.USD","IE00B42XCP33.USD","LU1267930573.SGD","LU0965508806.USD","LU0289739343.SGD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","RXL","LU0289961442.SGD","LU1244550577.SGD","LU1923622614.USD","LU1061106388.HKD","LU2112291526.USD","LU0553294199.USD","LU0859254822.USD","BK4534","LU1551013342.USD","LU0942090050.USD","LU1934455194.USD","VHT","LU0122379950.USD","LU2133065610.SGD","LU1732800096.USD","PJP","LU0058720904.USD","LU0545039389.USD","LU2089984988.USD","LU1934455863.HKD","BK4559","LU0795875086.SGD","LU0861579265.USD","SG9999001440.SGD","LU1929549753.HKD","BK4588","LU1093756168.USD","LU1670627923.USD","LU2468319806.SGD","GLAM","IE000SO60NU8.SGD","PPH","LU0726765562.USD","LU0289739699.SGD","AGNG","LU2129689605.HKD","LU0708994859.HKD","LU1244550221.USD","LU1989772840.SGD","LU0158827948.USD","LU0198837287.USD","IE00BFTCPJ56.SGD","LU0965509101.SGD","LU0128525929.USD","LU0820561818.USD","SG9999015945.SGD","SG9999015986.USD","XLV","IE00BVYPNW00.USD","BK4550","LU0689472784.USD","LU0965509283.SGD","IYH","LU1037948897.HKD","LU1551013425.SGD","LU0912757837.SGD","LU0949170772.SGD","LU0310799852.SGD","LU0472753341.HKD","BK4533","LU0203345920.USD","IE00BLSP4452.SGD","LU0057025933.USD","LU0823416689.USD","LU0170899867.USD","LU1989771016.USD","LU1037948541.HKD","LU2089284900.SGD","LU0689626769.HKD","IE00B19Z3581.USD","LU0203347892.USD","LU2023251221.USD","LU2125909593.SGD","LU2237443382.USD","LU0417517546.SGD","IE00BGHQF631.EUR","LU1244550494.USD","SG9999011175.SGD","IE00BJJMRZ35.SGD","JDOC","LU0256863902.USD","LU0795875169.SGD","LU0985320562.USD","FTXH","IE00BSNM7G36.USD","LU1162221912.USD","LU1989772923.USD","LU0943347566.SGD","LU0256863811.USD","FHLC","BK4585","LU1003077747.HKD","LU2347655156.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0310800379.SGD","LU2357627491.SGD","LU0965509010.AUD","IE00BLSP4239.USD","LU2087621335.USD","LU2089283258.USD","LU0661504455.SGD","IE0002270589.USD","IE0000B7K699.USD","LU2237443895.HKD","BK4566","LU0124676726.USD","LU0882574055.USD","LU1496350502.SGD","LU1839511570.USD","LU0820561909.HKD","LU0868494617.USD","SG9999003800.SGD","SG9999015952.SGD","LU2129689514.USD","LU1023059063.AUD","IE0002141913.USD","LU1983299246.USD","SG9999015978.USD","MEDX","IE00BN8TJ469.HKD","ABBV","IE00BDGV0183.EUR","IE0004445239.USD","LU1267930490.SGD","LU1732799900.SGD","LU0395794307.EUR","LU1074936037.SGD","LU2237443549.SGD","LU0868494708.USD","IE0009355771.USD","LU2237443465.HKD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121244940","title":"异动解读｜艾伯维公司盘中下跌3.15%，生物科技板块普跌叠加财报发布前夕承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1121244940","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121244940?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:57","pubTimestamp":1785423426,"startTime":"0","endTime":"0","summary":"7月30日，艾伯维公司盘中下跌3.15%，报255.805美元/股，成交额3.42亿美元。当日生物科技板块普遍走弱，行业内阿尔尼拉姆制药大跌逾26%，Madrigal跌超12%，吉利德科学跌超2%，安进跌近2%，板块抛压明显。公司将于7月31日发布第二季度财报，市场预期营收约167.60亿美元，同比增长11.54%，调整后每股收益3.57至3.61美元，同比增超24%。在连续利好推升股价后，财报发布前夕板块整体回调，公司股价随之承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117275596","title":"美股异动｜医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117275596","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117275596?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:29","pubTimestamp":1785248946,"startTime":"0","endTime":"0","summary":"7月28日，医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%，强生涨近3%，礼来涨超2%。消息面上，葛兰素史克公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","LLYX","ELIL","LLYZ","AMGN","LLII","JNJ","GSKH","PFE","ABBV","ELIS","LLY","MRK"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1147706356","title":"异动解读｜艾伯维公司盘中上涨3.06%，巴克莱上调目标价至300美元叠加财报预期催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1147706356","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147706356?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:23","pubTimestamp":1785248635,"startTime":"0","endTime":"0","summary":"7月28日，艾伯维公司盘中上涨3.06%，报266.48美元/股，成交额2.75亿美元。消息面上，巴克莱当日将艾伯维目标价从275美元上调至300美元，维持\"跑赢大盘\"评级，为近期机构给出的最高目标价。此外，公司将于7月31日发布第二季度财报，市场预期营收约167.60亿美元，同比增长11.54%，调整后每股收益3.57至3.61美元，同比增长超24%。近期Epcoritamab联合疗法获欧盟批准、Boey获欧盟上市许可、109亿美元收购Apogee强化免疫学布局等多重利好叠加，推动投资者情绪偏暖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007935","title":"解读世界500强榜单医药板块：强生继续“霸榜”，礼来排名上升112位，3家中国企业入选","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007935","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654007935?lang=zh_cn&edition=full","pubTime":"2026-07-28 20:51","pubTimestamp":1785243108,"startTime":"0","endTime":"0","summary":"7月28日，2026年《财富》世界500强榜单正式发布。《每日经济新闻》记者注意到，医疗健康板块作为全球五大支柱行业之一，共有31家企业上榜。其中，礼来公司排名从2025年的336位上升至今年的224位，成为今年上涨最快的10家公司之一。中国公司中，中国医药集团、上海医药、广药集团3家公司再次入围。《每日经济新闻》记者注意到，位居医疗健康相关企业榜首的是联合健康集团。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823749452.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823749452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B1XK9C88.USD","LU0106261372.USD","LU0320765489.SGD","SG9999001176.USD","LU2237443895.HKD","LU0052756011.USD","LU2242646821.SGD","LU0133085943.USD","LU0965509010.AUD","LU2106854487.HKD","LU2746668461.USD","IXJ","SG9999002232.USD","LU0211326839.USD","SGXZ99366536.SGD","LU2552382215.SGD","LU0820561909.HKD","IE00BVYPNW00.USD","LU1868837136.USD","LU1232071149.USD","MHIP","LU0342679015.USD","LU0211331839.USD","JNJ","LU2456880835.USD","CURE","IE00BVYPNV92.GBP","LU0070302665.USD","LU1196500208.SGD","LU1496350171.SGD","PBE","LU0251132253.USD","LU2089283258.USD","LU2023251221.USD","LU0211326755.USD","LU0395794307.EUR","LU2362541273.HKD","LU2089984988.USD","IE00BLSP4239.USD","SG9999011175.SGD","LU0472753341.HKD","LU1923622614.USD","LU2265009873.SGD","LU0203201768.USD","LU0353189763.USD","LU0786609619.USD","BK4588","LU0210536198.USD","SG9999017495.SGD","LU2125909593.SGD","LU0648001328.SGD","LU0985320562.USD","LU0289739343.SGD","RHHBY","LU2063271972.USD","LU0345770993.USD","IE0001KFT4U8.USD","SG9999014898.SGD","LU0158827948.USD","BK4533","IE00BKVL7J92.USD","LU2125154778.USD","IE00BKDWB100.SGD","LU2552382058.USD","LU0965508806.USD","LU1291159041.SGD","IE00BK4W5L77.USD","LU0320765059.SGD","LU0949170772.SGD","LU2756315664.SGD","LU1280957306.USD","IE000SO60NU8.SGD","LU0477156953.USD","LU1929549753.HKD","LU2750360997.AUD","SG9999015978.USD","LU1116320737.USD","LU1153585028.USD","LU2461242641.AUD","LU2362541513.USD","LU1145028129.USD","LU1221951129.SGD","SG9999015341.SGD","LU0234570918.USD","LU0882574139.USD","IE00B4R5TH58.HKD","LU0048584097.USD","LU0345770308.USD","LU1069344957.HKD","LU1571399168.USD","LU0203345920.USD","NVOX","IE00BBT3K403.USD","LU2471134879.HKD","IE00B19Z8X17.USD","LU0122379950.USD","MEDX","LU0234572021.USD","LU0426412945.USD","LU0708995401.HKD","LU0432979614.USD","LU0456855351.SGD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","BK4504","IE00BFSS8Q28.SGD","FTXH","PPH","LU0912757837.SGD","BK4559","LU0094547139.USD","LU0310800965.SGD","IE00BFXG1179.USD","LU0965509101.SGD","IE00B1BXHZ80.USD","JDOC","BK4532","LU2271345857.HKD","IE00B894F039.SGD","LU0964807845.USD","AGNG","LU0072461881.USD","SG9999003800.SGD","LU2087625088.SGD","LU0823434583.USD","LU1720051017.SGD","LU2471134796.USD","LU1868836591.USD","LU1839511570.USD","LU1551013425.SGD","LU2462591350.SGD","LU1228905540.USD","LU1623119135.USD","LU1228905037.USD","LU2592432038.USD","IE00BWXC8680.SGD","BK4516","SG9999015358.SGD","LU0511384066.AUD","LU2954938101.SGD","LU0130517989.USD","LU1261432733.SGD","LU0124676726.USD","LU0225771236.USD","SG9999014567.USD","LU0109391861.USD","UNHW","LU0053666078.USD","BK4585","SG9999014575.USD","LLYX","LU0198837287.USD","LU2129689514.USD","LU0943347566.SGD","LU0820561818.USD","LU1712237335.SGD","LU1732800096.USD","SG9999018857.SGD","LU0426417589.USD","LU0211328371.USD","LU0726765562.USD","LU2023250843.SGD","LU1244550577.SGD","LU1868837300.USD","LU0266013472.USD","LU2112291526.USD","LU1244550494.USD","PFE","LU1814569148.SGD","GLAM","IE00BJJMRY28.SGD","SG9999015952.SGD","UNH","BK4578","LU2168563687.JPY","04332","LU2237438978.USD","LU1074936037.SGD","LU1941712264.USD","LU2279689827.SGD","LU0321505439.SGD","LU0354030511.USD","LU2491049909.HKD","MRK","LU1804176565.USD","IBB","HRTS","IHF","IE00B42XCP33.USD","IE0002270589.USD","IE00BJJMRX11.SGD","IE000F7OJYX1.SGD","WDNA","ELIL","BK4568","LU1059921491.USD","SGXZ51526630.SGD","IE00BFSS7M15.SGD","LU1093756168.USD","LU1267930490.SGD","LU1670628061.USD","LU0882574055.USD","LU0061475181.USD","LU0471298777.SGD","LU0256863902.USD","LU0528227936.USD","IE00B2B36J28.USD","LU1989772840.SGD","IE00BZ1G4Q59.USD","LU2264538146.SGD","LU0225283273.USD","IE00B3PB1722.GBP","LU1935042991.SGD","LU0289739699.SGD","LU2347655073.USD","03165","LU1037948541.HKD","LU0306806265.USD","LU2750360641.GBP","LU0640476718.USD","LU2505996681.GBP","LU1974910355.USD","BK4581","LU2129689605.HKD","LU0985481810.HKD","LU1127390331.HKD","LU2237443382.USD","LU0170899867.USD","LU0323591593.USD","LU2242649171.HKD","TRUH","SGXZ57979304.SGD","LU1162221912.USD","BK4566","LU0128525689.USD","IE0000B7K699.USD","LU1244550221.USD","VHT","LU2896262040.SGD","LU0689472784.USD","LU1043141396.HKD","LU1989772923.USD","LU0545562505.USD","LU1035775433.USD","LU0553294199.USD","IE00B19Z9505.USD","IBBQ","LU0820562030.AUD","LU0689626769.HKD","SG9999014906.USD","RXL","BK4592","LU1720051108.HKD","LU2129689431.USD","LU2324357040.USD","LU1791710400.SGD","PAWZ","IE00BN29S564.USD","PJP","SG9999015945.SGD","LLY","BK4139","IE0005OL40V9.USD","LU1989771016.USD","LU0557290698.USD","LU1868836914.USD","LU2999663052.SGD","LU0889566641.SGD","LU2361045086.USD","LU2237443622.USD","FHLC","XLV","LU2213496289.HKD","LU0096364046.USD","LU1066051811.HKD","IE00B7KXQ091.USD","LU2125909247.SGD","LU1023059063.AUD","LU2471134952.CNY","LU1267930227.SGD","LU1221951046.USD","LU2168564065.EUR","IE0004445239.USD","IE00BJT1NW94.SGD","LU0069063385.USD","LU2357305700.SGD","LU2491050071.SGD","LU2108987350.USD","AMGN","LU0097036916.USD","LU0708994859.HKD","LU1496350502.SGD","LU1854103824.USD","IE000WAW04H5.SGD","IE00B19Z8W00.USD","TMED","LU0792757196.USD","SGXZ81514606.USD","LU2361044949.HKD","LU0672654240.SGD","LU2360106947.USD","LU1670627923.USD","LU2505996509.AUD","LU0795875086.SGD","LU1003077747.HKD","LU1732799900.SGD","LU2125154935.USD","LU2491050154.USD","LU2357627491.SGD","IE00BGHQF631.EUR","UNHG","MEDI","ELIS","LU1093756325.SGD","LU1032955483.USD","LU1057294990.SGD","IE00BDGV0183.EUR","SG9999013999.USD","LU0211327993.USD","IE0034235303.USD","LU0029864427.USD","LU0154236417.USD","LU1934455863.HKD","LU2111349929.HKD","LU2089284900.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","LU0661504455.SGD","LU0980610538.SGD","LU1066051498.USD","SG9999014559.SGD","LU2430703178.SGD","LU0107464264.USD","SG9999014542.SGD","LU0320765992.SGD","ILDR","LU0128525929.USD","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU1116320901.HKD","LU2347655156.SGD","LU2471134523.USD","LU0545039389.USD","LU0868494617.USD","LU1064131342.USD","ABBV","LU0385154629.USD","LU0149725797.USD","LU2168564222.USD","LU2244417387.USD","BIB","LU1548497426.USD","LU0203202063.USD","LU0738911758.USD","LU1119994496.HKD","LU2361044865.SGD","LU1718418525.SGD","LU1043141123.HKD","LU0225284248.USD","LU1551013342.USD","THNR","LU1791710582.SGD","LU1894683264.USD","LU2028103732.USD","BBH","LU1854104046.USD","IE0004445015.USD","LU1988902786.USD","LU2133065610.SGD","LU0965509283.SGD","LU1061106388.HKD","LU0058720904.USD","LU0859254822.USD","LU1868836757.USD","LU2211815571.USD","SG9999002224.SGD","LU0417517546.SGD","LU2242652126.USD","SGXZ31699556.SGD","LU0162691827.USD","LU1267930573.SGD","LU2417539215.USD","IE00B19Z9Z06.USD","LU1699723380.USD","BK4007","LU0795875169.SGD","LU2236285917.USD","LU2433249047.HKD","LU2462591277.SGD","NVO","NVS","LU0861579265.USD","BMED","LU0353189680.USD","LU1934455194.USD","SG9999001176.SGD","LU1894683348.USD","LU0265550359.USD","LU0098860793.USD","LU0289961442.SGD","IE00B7SZLL34.SGD","LU2023250504.SGD","LU1914381329.SGD","IE0002141913.USD","IE00B4JS1V06.HKD","LU0210528500.USD","LU1674673428.USD","IE00B3T34201.USD","LU2746668974.SGD","LU2462157665.USD","LU0310799852.SGD","LU0889565916.HKD","OZEM","TBXU","LU0006306889.USD","BK4550","SG9999001440.SGD","LU2237443549.SGD","LU0496365809.HKD","IE00B775H168.HKD","LLII","GB00BDT5M118.USD","LU0077335932.USD","LU0354030438.USD","LU2087621335.USD","LU2237443978.SGD","LU1035773651.USD","LU0079474960.USD","IE00BK4W5M84.HKD","LU1674673691.USD","LU1066051225.USD","IE00B19Z9P08.USD","LU2168564149.EUR","LU1032466523.USD","LU0238689110.USD","IE00BN8TJ469.HKD","LU0070217475.USD","LU0994945656.USD","LU2552382132.HKD","LU1585245621.USD","LU0203347892.USD","IE00BZ9MQY76.HKD","LU0114720955.EUR","LU0011850046.USD","LU1267930813.SGD","LU2602419157.SGD","SG9999015986.USD","IHE","LU1121112475.USD","LU1883839398.USD","LU2237443465.HKD","LU0471298694.HKD","LU0345769128.USD","LU2430703095.HKD","LU0109394709.USD","LU0823416689.USD","IE000MB6IJN5.SGD","LU1366192091.USD","LU2023250330.USD","NVOH","SG9999014880.SGD","IE00B19Z3581.USD","LU1983299246.USD","LU1778281490.HKD","SG9999018865.SGD","LU0823434740.USD","LU1037948897.HKD","LU1629891620.HKD","LU2360032135.SGD","LU0143551892.USD","LU0320765646.SGD","LU1934455277.USD","LU2403377893.USD","LU0187121727.USD","SG9999014914.USD","BK4599","LU0316494557.USD","LU0057025933.USD","IYH","LU1084165304.USD","LU2596442595.SGD","LU2168564495.EUR","LU0310800379.SGD","LU0265550946.USD","LU1430594728.SGD","LU0174119429.USD","LU0208291251.USD","LU0345769631.USD","LU2430703251.USD","CANC","LU1941712348.USD","LU2487616109.SGD","UNHU","LU0130102774.USD","LU1201861249.SGD","LU1323610961.USD","LU0466842654.USD","BK4154","LU2362540622.SGD","LU0683600562.USD","GDOC","LU0256863811.USD","IE0009355771.USD","LU0306807586.USD","LU2756315318.SGD","IE00BKPKM429.USD","LU0976567544.SGD","LU2468319806.SGD","LU1267930730.SGD","LU1917777945.USD","IE00BSNM7G36.USD","IE000BZT7R73.USD","LU0942090050.USD","LU0787776722.HKD","LLYZ","LU0158827781.USD","LU1069347547.HKD","LU0868494708.USD","IE00BJLML261.HKD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":-0.0218},{"period":"1month","weight":0.0361},{"period":"3month","weight":0.1974},{"period":"6month","weight":0.119},{"period":"1year","weight":0.2357},{"period":"ytd","weight":0.1379}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.01},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.181},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.5,"avgChangeRate":0.011241},{"month":8,"riseRate":0.571429,"avgChangeRate":0.008439},{"month":9,"riseRate":0.571429,"avgChangeRate":0.014868},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}